Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial

BACKGROUND: Breast cancer becomes lethal when visceral metastases develop. At this stage, anti-cancer treatments aim at relieving symptoms and delaying death without resulting in additional toxicity. On the basis of their differential anti-oxidant defence level, tumour cells can be made more sensiti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Bougnoux, P, Hajjaji, N, Ferrasson, M N, Giraudeau, B, Couet, C, Le Floch, O
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2009
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2779856/
https://ncbi.nlm.nih.gov/pubmed/19920822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605441
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados